Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults
- 21 January 2026
- journal article
- other
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 61 (4) , 487-489
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudilBone Marrow Transplantation, 2025
- Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion studyBlood Advances, 2025
- Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular TherapyBone Marrow Transplantation, 2025
- Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysisBone Marrow Transplantation, 2025
- Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trialsBlood Advances, 2022
- Three US Food and Drug Administration–approved therapies for chronic GVHDBlood, 2022
- Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar StudyBlood, 2021
- ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host DiseaseJournal of Clinical Oncology, 2021
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2015
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015